139 related articles for article (PubMed ID: 20219442)
1. Altered expression of neuronal nitric oxide synthase in weaver mutant mice.
Cavalcanti-Kwiatkoski R; Raisman-Vozari R; Ginestet L; Del Bel E
Brain Res; 2010 Apr; 1326():40-50. PubMed ID: 20219442
[TBL] [Abstract][Full Text] [Related]
2. A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway.
Gomes MZ; Raisman-Vozari R; Del Bel EA
Brain Res; 2008 Apr; 1203():160-9. PubMed ID: 18313645
[TBL] [Abstract][Full Text] [Related]
3. Developmental expression of neuronal nitric oxide synthase in P/Q-type voltage-gated calcium ion channel mutant mice, leaner and tottering.
Frank-Cannon TC; Zeve DR; Abbott LC
Brain Res; 2007 Apr; 1140():96-104. PubMed ID: 16359645
[TBL] [Abstract][Full Text] [Related]
4. Girk2 expression in the ventral midbrain, cerebellum, and olfactory bulb and its relationship to the murine mutation weaver.
Schein JC; Hunter DD; Roffler-Tarlov S
Dev Biol; 1998 Dec; 204(2):432-50. PubMed ID: 9882481
[TBL] [Abstract][Full Text] [Related]
5. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
6. The weaver gene expression affects neuronal generation patterns depending on age and encephalic region.
Martí J; Carmen Santa-Cruz M; Bayer SA; Hervás JP
Neurosci Lett; 2006 Apr; 396(3):202-6. PubMed ID: 16387438
[TBL] [Abstract][Full Text] [Related]
7. Regional brain variations of cytochrome oxidase activity and motor coordination in Girk2(Wv) (Weaver) mutant mice.
Strazielle C; Deiss V; Naudon L; Raisman-Vozari R; Lalonde R
Neuroscience; 2006 Oct; 142(2):437-49. PubMed ID: 16844307
[TBL] [Abstract][Full Text] [Related]
8. The weaver GIRK2 mutation leads to decreased levels of serum thyroid hormone: characterization of the effect on midbrain dopaminergic neuron survival.
Blum M; Weickert C; Carrasco E
Exp Neurol; 1999 Dec; 160(2):413-24. PubMed ID: 10619558
[TBL] [Abstract][Full Text] [Related]
9. Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: the effects of chronic treatment with l-DOPA and the nitric oxide donor, molsidomine.
Czarnecka A; Lenda T; Domin H; Konieczny J; Smiałowska M; Lorenc-Koci E
Brain Res; 2013 Dec; 1541():92-105. PubMed ID: 24129225
[TBL] [Abstract][Full Text] [Related]
10. Role of p38 and inducible nitric oxide synthase in the in vivo dopaminergic cells' degeneration induced by inflammatory processes after lipopolysaccharide injection.
Ruano D; Revilla E; Gavilán MP; Vizuete ML; Pintado C; Vitorica J; Castaño A
Neuroscience; 2006 Jul; 140(4):1157-68. PubMed ID: 16713109
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide synthase inhibition and MPTP-induced toxicity in the common marmoset.
Mackenzie GM; Jackson MJ; Jenner P; Marsden CD
Synapse; 1997 Jul; 26(3):301-16. PubMed ID: 9183819
[TBL] [Abstract][Full Text] [Related]
12. Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants.
Gaillard A; Decressac M; Frappé I; Fernagut PO; Prestoz L; Besnard S; Jaber M
Neurobiol Dis; 2009 Sep; 35(3):477-88. PubMed ID: 19616502
[TBL] [Abstract][Full Text] [Related]
13. Tolerance to the cataleptic effect that follows repeated nitric oxide synthase inhibition may be related to functional enzymatic recovery.
Del-Bel EA; Guimarães FS; Joca SR; Echeverry MB; Ferreira FR
J Psychopharmacol; 2010 Mar; 24(3):397-405. PubMed ID: 18838497
[TBL] [Abstract][Full Text] [Related]
14. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
[TBL] [Abstract][Full Text] [Related]
15. Excitatory amino acids, monoamine, and nitric oxide synthase systems in organotypic cultures: biochemical and immunohistochemical analysis.
Herrera-Marschitz M; Kohlhauser C; Gomez-Urquijo S; Ubink R; Goiny M; Hökfelt T
Amino Acids; 2000; 19(1):33-43. PubMed ID: 11026471
[TBL] [Abstract][Full Text] [Related]
16. Effect of the weaver mutation on the expression of dopamine membrane transporter, tyrosine hydroxylase and vesicular monoamine transporter in dopaminergic neurons of the substantia nigra and the ventral tegmental area.
Adelbrecht C; Agid Y; Raisman-Vozari R
Brain Res Mol Brain Res; 1996 Dec; 43(1-2):291-300. PubMed ID: 9037545
[TBL] [Abstract][Full Text] [Related]
17. Alterations in expression of dopamine receptors and neuropeptides in the striatum of GTP cyclohydrolase-deficient mice.
Zeng BY; Heales SJ; Canevari L; Rose S; Jenner P
Exp Neurol; 2004 Dec; 190(2):515-24. PubMed ID: 15530890
[TBL] [Abstract][Full Text] [Related]
18. Maturation but not survival of dopaminergic nigrostriatal neurons is affected in developing and aging BDNF-deficient mice.
Baker SA; Stanford LE; Brown RE; Hagg T
Brain Res; 2005 Mar; 1039(1-2):177-88. PubMed ID: 15781060
[TBL] [Abstract][Full Text] [Related]
19. Differential activation of astrocytes and microglia during post-natal development of dopaminergic neuronal death in the weaver mouse.
Douhou A; Debeir T; Michel PP; Stankovski L; Oueghlani-Bouslama L; Verney C; Raisman-Vozari R
Brain Res Dev Brain Res; 2003 Oct; 145(1):9-17. PubMed ID: 14519489
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs.
Seroogy KB; Lundgren KH; Tran TM; Guthrie KM; Isackson PJ; Gall CM
J Comp Neurol; 1994 Apr; 342(3):321-34. PubMed ID: 7912699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
